TY  - GEN
AU  - Mount,G R
AU  - Gilliland,W R
TI  - Emerging biological therapies in systemic lupus erythematosus
SN  - 1532-6535
PY  - 2008///0124
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Antigens, CD
KW  - immunology
KW  - Antigens, CD20
KW  - Antigens, Differentiation
KW  - B-Cell Activating Factor
KW  - antagonists & inhibitors
KW  - Biological Therapy
KW  - trends
KW  - CD11a Antigen
KW  - CD40 Ligand
KW  - CTLA-4 Antigen
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Lupus Erythematosus, Systemic
KW  - drug therapy
KW  - Patient Selection
KW  - Prognosis
KW  - Sialic Acid Binding Ig-like Lectin 2
KW  - Tumor Necrosis Factor-alpha
N1  - Publication Type: Journal Article; Review
UR  - https://doi.org/10.1038/sj.clpt.6100436
ER  -